FDA.reportPublic FDA data

treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)

RxCUI
2641911
RxNorm name
treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)
Display name
treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)
Full name
treprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)SY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0ftreprostinil 48-64 MCG Maintenance Pack, 112 (48 MCG), 112 (64 MCG)PSN14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f{112 (treprostinil 0.048 MG Inhalation Powder) / 112 (treprostinil 0.064 MG Inhalation Powder) } PackGPCK14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120